Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Mometasone
Active Ingredient: Mometasone furoate monohydrate 0.5173mg/g
Dosage Form: Nasal spray suspension
New Zealand Sponsor: Neo Pharma Limited
Manufacturer: Farmea, Angers, France
   
Product: Mytolac
Active Ingredient: Lanreotide acetate 27.3%w/w equivalent to lanreotide 60mg
Dosage Form: Solution for injection
New Zealand Sponsor: Boucher & Muir (NZ) Limited t/a Mercury Pharma (NZ)
Manufacturers: Pharmathen SA, Pallini, Greece
Synergy Health Ede B.V., Ede, Netherlands
Pharmathen International SA, Rodopi, Greece
Sterigenics Belgium (Fleurus) SA, Fleurus, Belgium
   
Product: Mytolac
Active Ingredient: Lanreotide acetate 27.3%w/w equivalent to lanreotide 90mg
Dosage Form: Solution for injection
New Zealand Sponsor: Boucher & Muir (NZ) Limited t/a Mercury Pharma (NZ)
Manufacturers: Pharmathen SA, Pallini, Greece
Synergy Health Ede B.V., Ede, Netherlands
Pharmathen International SA, Rodopi, Greece
Sterigenics Belgium (Fleurus) SA, Fleurus, Belgium
   
Product: Mytolac
Active Ingredient: Lanreotide acetate 27.3%w/w equivalent to lanreotide 120mg
Dosage Form: Solution for injection
New Zealand Sponsor: Boucher & Muir (NZ) Limited t/a Mercury Pharma (NZ)
Manufacturers: Pharmathen SA, Pallini, Greece
Synergy Health Ede B.V., Ede, Netherlands
Pharmathen International SA, Rodopi, Greece
Sterigenics Belgium (Fleurus) SA, Fleurus, Belgium
   
Product: Telnasal Allergy Spray
Active Ingredient: Mometasone furoate monohydrate 0.5173mg/g
Dosage Form: Nasal spray suspension
New Zealand Sponsor: Neo Pharma Limited
Manufacturer: Farmea, Angers, France


Dated this 11th day of November 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).